简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

CEro Therapeutics任命Chris Ehrlich首席执行官

2024-12-06 23:12

  • CERo Therapeutics Holdings (NASDAQ:CERO) has appointed Chris Ehrlich as CEO. 
  • Previously Ehrlich held the position of Interim CEO.
  • In addition to his role at CERo, Ehrlich currently serves as CEO of Launch One Acquisition Corporation.
  • CERO shares were down 29.5% on Friday. 
  • Source: Press Release

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。